Senseonics to Participate in the Jefferies Healthcare Conference

Rhea-AI Summary

Senseonics Holdings, Inc. (AMEX: SENS) announced its participation in the Jefferies Healthcare Conference in New York, scheduled for June 9, 2022, at 1:30pm ET. The presentation will be accessible via a live and recorded webcast on the company's website. Senseonics specializes in developing long-term, implantable continuous glucose monitoring systems, including Eversense® devices, designed to aid diabetes management. The company aims to transform lives by providing innovative glucose monitoring solutions.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

Management is scheduled to present on Thursday, June 9, 2022 at 1:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005699/en/

Senseonics Investor Relations Contact:

Philip Taylor

Investor Relations

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When is Senseonics presenting at the Jefferies Healthcare Conference?

Senseonics is scheduled to present on June 9, 2022, at 1:30pm ET.

Where can I watch the Senseonics presentation at the conference?

The presentation will be available via a live and recorded webcast on Senseonics' website.

What is the focus of Senseonics Holdings, Inc.?

Senseonics focuses on developing long-term, implantable continuous glucose monitoring systems for diabetes management.

What products does Senseonics offer for glucose monitoring?

Senseonics offers glucose monitoring products including Eversense®, Eversense® XL, and Eversense® E3.

What is the ticker symbol for Senseonics?

The ticker symbol for Senseonics is SENS.